• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Semper Paratus Acquisition Corporation (Amendment)

    7/21/23 8:56:23 AM ET
    $LGST
    Blank Checks
    Finance
    Get the next $LGST alert in real time by email
    SC 13G/A 1 ff2300394_13ga1-semper.htm
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    SCHEDULE 13G
    (Amendment No. 1)*
    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    Semper Paratus Acquisition Corp.
    (Name of Issuer)
    Class A ordinary shares, par value $0.0001 per share
    (Title of Class of Securities)
    G8028L107
    (CUSIP Number)
    July 17, 2023
    (Date of Event Which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    ☐
    Rule 13d-1(b)
     
    ☑
    Rule 13d-1(c)
     
    ☐
    Rule 13d-1(d)
    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    CUSIP No.
    G8028L107
     
    1
    NAMES OF REPORTING PERSONS
     
     
    Corbin Capital Partners, L.P.
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    0
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    0
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    0
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    0%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    PN
     
     
     
     


    CUSIP No.
    G8028L107
     
    1
    NAMES OF REPORTING PERSONS
     
     
    Corbin Capital Partners GP, LLC
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    United States
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    0
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    0
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    0
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    0%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    OO
     
     
     
     



    Item 1(a)
    Name of Issuer
    The name of the issuer is Semper Paratus Acquisition Corp. (the “Company”).
    Item 1(b)
    Address of Issuer’s Principal Executive Offices
    The Company’s principal executive offices are located at 767 Third Avenue, 38th Floor, New York, New York 10017.
    Item 2(a)
    Name of Person Filing
    This statement is filed by on behalf of the following persons (collectively, the “Reporting Persons”):
    (i)    Corbin Capital Partners, L.P., a Delaware limited partnership
    (ii)   Corbin Capital Partners GP, LLC, a Delaware limited liability company
    Item 2(b)
    Address of Principal Business Office or, if None, Residence
    The address of the business office of each of the Reporting Persons is 590 Madison Avenue, 31st Floor, New York, NY 10022.
    Item 2(c)
    Citizenship
    The Reporting Persons are organized under the laws of the State of Delaware.
    Item 2(d)
    Title of Class of Securities
    Class A ordinary shares, par value $0.0001 per share (“Ordinary Shares”).
    Item 2(e)
    CUSIP No.
    G8028L107
    Item 3.
    If This Statement Is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

    Not Applicable.

    Item 4.
    Ownership

    The information in Items 5 through 9 and Item 11 on the cover pages to this Schedule 13G is hereby incorporated by reference.

    The percentages used herein are calculated based upon 15,816,386 Ordinary Shares reported to be outstanding as of May 22, 2023, as reported in the Company’s Quarterly Report on Form 10-Q, as filed with the Securities and Exchange Commission on May 22, 2023.



    Item 5.
    Ownership of Five Percent or Less of a Class
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check following ☒.
    Item 6.
    Ownership of More Than Five Percent on Behalf of Another Person
    Not Applicable.
    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
    The information in Items 2 and 4 is hereby incorporated by reference.
    Item 8.
    Identification and Classification of Members of the Group
    Not Applicable.
    Item 9.
    Notice of Dissolution of Group
    Not Applicable.
    Item 10.
    Certification
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURES
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: July 19, 2023

     
    Corbin Capital Partners L.P.
     
     
     
     
     
    By:
    /s/ Daniel Friedman
     
     
     
    Name:
    Daniel Friedman
     
     
     
    Title:
    General Counsel
     
     
     
     
     
     
    Corbin Capital Partners GP, LLC 
     
     
     
    By:
    /s/ Daniel Friedman
     
     
     
    Name:
    Daniel Friedman
     
       
    Title:
    Authorized Signatory
     


    Get the next $LGST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LGST

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LGST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGN

    Listing on Nasdaq is expected to provide Tevogen Bio Holdings Inc. increased access to capital to accelerate development of its genetically unmodified off-the-shelf T cell therapy products for large patient populations. WARREN, N.J., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. ("Tevogen Bio"), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in virology, oncology, and neurology, has announced the completion of Tevogen Bio Inc's previously announced business combination with Semper Paratus Acquisition Corporation, leading to the formation of Tevogen Bio Holdings Inc. The combined company's common s

    2/14/24 3:55:00 PM ET
    $LGST
    Blank Checks
    Finance

    Semper Paratus Acquisition Corporation's Shareholders Approve Business Combination with Tevogen Bio

    New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation ("Semper Paratus") (NASDAQ:LGST, LGSTW, LGSTU))), a publicly-traded special purpose acquisition company, announced today that its shareholders have approved the proposed business combination (the "Business Combination") with Tevogen Bio Inc, a Delaware corporation ("Tevogen Bio"), at an extraordinary general meeting of Semper Paratus' shareholders that was held on Wednesday, January 31, 2024 (the "Meeting"). Each of the proposals presented at the Meeting was approved, and the Business Combination is expected to be consummated as soon as practicable following the satisfaction or waiver of the remaining c

    2/1/24 8:15:00 AM ET
    $LGST
    Blank Checks
    Finance

    Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq

    New York, NY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation ("Semper Paratus") (NASDAQ:LGST, LGSTW))), a publicly-traded special purpose acquisition company, today announced that it has filed a supplement ("Prospectus Supplement") to its definitive proxy statement/prospectus dated January 10, 2024 (the "Proxy Statement/Prospectus") for the solicitation of proxies in connection with the extraordinary general meeting of Semper Paratus' shareholders scheduled to be held on January 29, 2024, to consider and vote on, among other proposals as more fully set forth in the Proxy Statement/Prospectus, the transactions (collectively, the "Business Combination") contemplated

    1/24/24 4:05:00 PM ET
    $LGST
    Blank Checks
    Finance

    $LGST
    SEC Filings

    View All

    Semper Paratus Acquisition Corporation filed SEC Form 8-K: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics, Financial Statements and Exhibits

    8-K - Tevogen Bio Holdings Inc. (0001860871) (Filer)

    2/21/24 4:30:46 PM ET
    $LGST
    Blank Checks
    Finance

    Semper Paratus Acquisition Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Unregistered Sales of Equity Securities, Financial Statements and Exhibits (Amendment)

    8-K/A - Tevogen Bio Holdings Inc. (0001860871) (Filer)

    2/20/24 8:57:33 AM ET
    $LGST
    Blank Checks
    Finance

    SEC Form 8-A12B filed by Semper Paratus Acquisition Corporation

    8-A12B - Semper Paratus Acquisition Corp (0001860871) (Filer)

    2/14/24 5:20:14 PM ET
    $LGST
    Blank Checks
    Finance

    $LGST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Desai Kirti was granted 9,696,186 shares (SEC Form 4)

    4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)

    2/16/24 5:30:03 PM ET
    $LGST
    Blank Checks
    Finance

    Goh Keow Lin was granted 193,923 shares (SEC Form 4)

    4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)

    2/16/24 5:29:11 PM ET
    $LGST
    Blank Checks
    Finance

    Patton Curtis L. was granted 969,618 shares (SEC Form 4)

    4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)

    2/16/24 5:28:35 PM ET
    $LGST
    Blank Checks
    Finance

    $LGST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Semper Paratus Acquisition Corporation

    SC 13D - Tevogen Bio Holdings Inc. (0001860871) (Subject)

    2/22/24 8:13:20 PM ET
    $LGST
    Blank Checks
    Finance

    SEC Form SC 13D filed by Semper Paratus Acquisition Corporation

    SC 13D - Tevogen Bio Holdings Inc. (0001860871) (Subject)

    2/22/24 8:09:42 PM ET
    $LGST
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Semper Paratus Acquisition Corporation (Amendment)

    SC 13G/A - Semper Paratus Acquisition Corp (0001860871) (Subject)

    2/14/24 4:58:16 PM ET
    $LGST
    Blank Checks
    Finance